Parallel Synthesis of Diarylureas and Their Evaluation as Inhibitors of Insulin-Like Growth Factor Receptor-Reference-Cited by-同舟云学术

Parallel Synthesis of Diarylureas and Their Evaluation as Inhibitors of Insulin-Like Growth Factor Receptor

Published:2006-08-16 Issue:5 Volume:8 Page:784-790
ISSN:1520-4766
Container-title:Journal of Combinatorial Chemistry
language:en
Short-container-title:J. Comb. Chem.

Author:

Anderson Marc O.¹,Yu Hong¹,Penaranda Cristina¹,Maddux Betty A.¹,Goldfine Ira D.¹,Youngren Jack F.¹,Guy R. Kiplin¹

Affiliation:

1. Department of Pharmaceutical Chemistry, University of California, Box 2280, San Francisco, California 94143-2280, Diabetes and Endocrine Research, University of California, Box 1616, San Francisco, California 94143-1616, and Department of Cellular and Molecular Pharmacology, University of California, San Francisco, Box 2280, California 94143-2280

Publisher

American Chemical Society (ACS)

Subject

General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/cc050136z

Reference18 articles.

1. The new kid on the block(ade) of the IGF-1 receptor

2. Inhibitors of angiogenesis and cancer-related receptor tyrosine kinases

3. Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice.

4. Cellular Actions of the Insulin-Like Growth Factor Binding Proteins

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer and insulin-like growth factor inhibitors: Recent advancements and SAR analysis;Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy;2024

2. “Urea to Urea” Approach: Access to Unsymmetrical Ureas Bearing Pyridyl Substituents;Advanced Synthesis & Catalysis;2022-03-08

3. Fast and controlled ring-opening polymerization of δ-valerolactone catalyzed by benzoheterocyclic urea/MTBD catalysts;Catalysis Science & Technology;2020

4. Idebenone is a cytoprotective insulin sensitizer whose mechanism is Shc inhibition;Pharmacological Research;2018-11

5. Pharmacophore modeling for identification of anti-IGF-1R drugs and in-vitro validation of fulvestrant as a potential inhibitor;PLOS ONE;2018-05-22